Global Down Syndrome

Spring 2015

Issue link: https://viewer.e-digitaledition.com/i/518721

Contents of this Issue

Navigation

Page 7 of 31

CONTINUED ON PAGE 10 COULD DOWN SYNDROME RESEARCH LEAD TO A CURE FOR CANCER? CHILDREN WITH DOWN SYNDROME are more at risk for leukemia, a blood cancer, than their typical peers. At the same time, people with Down syndrome have a significantly lower risk than the typical population of developing solid tumors that cause breast, colon, and other aggressive cancers. "So far, we do not understand why people with Down syndrome have a significantly decreased frequency of tumors," said Tom Blumenthal, Ph.D., Executive Director of the Linda Crnic Institute for Down Syndrome. "Understanding the elements that can prevent cancer would be a tremendous contribution individuals with Down syndrome could make to the world." MULTIPLE THEORIES OF TUMOR PROTECTION Down syndrome is caused by having three copies of chromosome 21 instead of two, and it's the "overexpression" of that chromosome that is the primary focus of current research into Down syndrome and cancer genetics. There are many genes on chromosome 21 that appear to influence the formation — or suppression — of cancer, as well as how cancers respond to treatment. Dr. Blumenthal outlines several theories scientists are studying: • Tumors cannot grow because of poor stem cell division. The extra copy of chromosome 21 is already known to cause deficiencies in cell division in people with Down syndrome, such as hypothalamic cells that control appetite and weight, Dr. Blumenthal said. Scientists have theorized that stem cells required to produce tumors in individuals with Down syndrome may not be able to divide quickly enough to form a cancer. Another possibility may be the increased presence of amyloid precursor protein (APP), which also lives on chromosome 21. When present in larger amounts, APP can inhibit cell division. • Tumors are not fed by the circulatory system. As with healthy cells, tumor cells need oxygen and nutrients carried by blood vessels in order to thrive. Chromosome 21 carries a gene that, when overexpressed, could suppress angiogenesis, or the development of blood vessels that feed a tumor. • Tumors are directly suppressed by a specific gene. "The 'tumor-suppressor gene' hypothesis postulates that chromosome 21 contains one or more genes that naturally slow down tumor growth," said Joaquin Espinosa, Ph.D., Associate Professor in the Department of Molecular, Cellular, and Developmental Biology at the University of Colorado Boulder and Howard Hughes Medical Institute Early Career Scientist. "An extra copy of these genes would increase the body's ability to protect itself from cancer development and progression." Dr. Espinosa, one of the country's foremost researchers on cancer genetics and a Crnic Grand Challenge Grant recipient, added that these genes could be responsible for suppressing angiogenesis or tumor cell division, or there could be some other unknown mechanism by which they work. His lab is making use of a technique called functional genomics to identify genes that control how cells from individuals with Down RESEARCH INTO THE GENETIC MECHANISMS OF SOLID TUMORS AND LEUKEMIA IN INDIVIDUALS WITH DOWN SYNDROME COULD HOLD PROMISING NEW DISCOVERIES FOR EVERYONE WITH CANCER. Joaquin Espinosa, Ph.D., cancer and molecular biologist Tom Blumenthal, Ph.D., upper lef t, molecular biologist SPRING2015 DOWN SYNDROME WORLD 8

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - Spring 2015